Search Results - "Zeymer, U"

Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-ACS admissions by Gitt, A. K., Karcher, A. K., Zahn, R., Zeymer, U.

Get full text

Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries by Widimsky, Petr, Wijns, William, Fajadet, Jean, de Belder, Mark, Knot, Jiri, Aaberge, Lars, Andrikopoulos, George, Baz, Jose Antonio, Betriu, Amadeo, Claeys, Marc, Danchin, Nicholas, Djambazov, Slaveyko, Erne, Paul, Hartikainen, Juha, Huber, Kurt, Kala, Petr, Klinčeva, Milka, Kristensen, Steen Dalby, Ludman, Peter, Ferre, Josephina Mauri, Merkely, Bela, Miličić, Davor, Morais, Joao, Noč, Marko, Opolski, Grzegorz, Ostojić, Miodrag, Radovanovič, Dragana, De Servi, Stefano, Stenestrand, Ulf, Studenčan, Martin, Tubaro, Marco, Vasiljević, Zorana, Weidinger, Franz, Witkowski, Adam, Zeymer, Uwe

“…Aims Patient access to reperfusion therapy and the use of primary percutaneous coronary intervention (p-PCI) or thrombolysis (TL) varies considerably between…”
Get full text

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis by Silvain, Johanne, Beygui, Farzin, Barthélémy, Olivier, Pollack, Charles, Cohen, Marc, Zeymer, Uwe, Huber, Kurt, Goldstein, Patrick, Cayla, Guillaume, Collet, Jean-Philippe, Vicaut, Eric, Montalescot, Gilles

“…Objective To determine the efficacy and safety of enoxaparin compared with unfractionated heparin during percutaneous coronary intervention.Design Systematic…”
Get full text

Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology by Steg, Philippe Gabriel, Huber, Kurt, Andreotti, Felicita, Arnesen, Harald, Atar, Dan, Badimon, Lina, Bassand, Jean-Pierre, De Caterina, Raffaele, Eikelboom, John A., Gulba, Dietrich, Hamon, Martial, Helft, Gérard, Fox, Keith A.A., Kristensen, Steen D., Rao, Sunil V., Verheugt, Freek W.A., Widimský, Petr, Zeymer, Uwe, Collet, Jean-Philippe

“…Bleeding has recently emerged as an important outcome in the management of acute coronary syndromes (ACS), which is relatively frequent compared with ischaemic…”
Get full text

Community-based analysis of stroke prevention and effect of public interventions in atrial fibrillation: results from the ARENA project by Zylla, Maura M, Özdemir, Belgin, Hochadel, Matthias, Zeymer, U, Akin, Ibrahim, Grau, Armin, Schneider, Steffen, Alonso, Angelika, Waldecker, Bernd, Süselbeck, Tim, Schwacke, Harald, Haass, Markus, Zahn, Ralf, Borggrefe, Martin, Senges, Jochen, Frey, Norbert, Thomas, Dierk

“…Community-based interventions may promote awareness and adherence to atrial fibrillation (AF)-related therapies, potentially reducing adverse events. The ARENA…”
Get full text

Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis by De Luca, G, Gibson, C M, Bellandi, F, Murphy, S, Maioli, M, Noc, M, Zeymer, U, Dudek, D, Arntz, H-R, Zorman, S, Gabriel, H M, Emre, A, Cutlip, D, Biondi-Zoccai, G, Rakowski, T, Gyongyosi, M, Marino, P, Huber, K, van't Hof, A W J

“…Even though time-to-treatment has been shown to be a determinant of mortality in primary angioplasty, the potential benefits from early pharmacological…”
Get more information

Prospective 'real world' registry for the use of the 'PCB only' strategy in small vessel de novo lesions by Zeymer, U, Waliszewski, M, Spiecker, M, Gastmann, O, Faurie, B, Ferrari, M, Alidoosti, M, Palmieri, C, Heang, T N, Ong, P Jl, Dietz, U

“…This prospective registry assessed the safety and efficacy of paclitaxel coated balloon (PCB) angioplasty for small vessel coronary artery disease in Europe…”
Get more information

EU-CaRE study: Could exercise-based cardiac telerehabilitation also be cost-effective in elderly? by Scherrenberg, M., Zeymer, U., Schneider, S., Van der Velde, A.E., Wilhelm, M., Van’t Hof, A.W.J., Kolkman, E., Prins, L.F., Prescott, E., Iliou, M.C., Peña-Gil, C., Ardissino, D., De Kluiver, E.P., Dendale, P.

“…The role of cardiac rehabilitation (CR) is well established in the secondary prevention of ischemic heart disease. Unfortunately, the participation rates…”
Get full text

Editor’s Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association by Walker, DM, Gale, CP, Lip, G, Martin-Sanchez, FJ, McIntyre, HF, Mueller, C, Price, S, Sanchis, J, Vidan, MT, Wilkinson, C, Zeymer, U, Bueno, H

“…Frailty is increasingly seen among patients with acute cardiovascular disease. A combination of an ageing population, improved disease survival, treatable…”
Get full text

ARENA-Project atrial fibrillation in the Rhein-Neckar region by Baumann, S, Grau, A, Senges, J, Schneider, S, Alonso, A, Katus, H A, Thomas, D, Waldecker, B, Haass, M, Zahn, R, Zeymer, U, Akin, I, Kruska, M, Fischer, C, Borggrefe, M

“…Atrial fibrillation (AF) is the most common form of cardiac tachyarrhythmia. It is estimated that in the Rhein-Neckar region approximately 40,000-50,000 out of…”
Get full text

Antithrombotic therapy and atrial fibrillation. Dual or triple therapy after acute coronary syndrome and stent? by Zeymer, U, Zahn, R

“…Current guidelines recommend dual antiplatelet therapy preferably with prasugrel or ticagrelor for 12 months in patients after acute coronary syndrome with…”
Get full text

Differences in clinical and angiographic profiles between Asian and Western patients with coronary artery disease: Insights from the prospective “real world” paclitaxel-coated balloon registry by Ong, Paul Jau Lueng, Zeymer, U, Waliszewski, M, Tan, Julian, Ho, Hee Hwa

Get full text

Two-year Vascular Hospitalisation Rates and Associated Costs in Patients at Risk of Atherothrombosis in France and Germany: Highest Burden for Peripheral Arterial Disease by Smolderen, K.G, Wang, K, de Pouvourville, G, Brüggenjürgen, B, Röther, J, Zeymer, U, Parhofer, K.G, Steg, P.G, Bhatt, D.L, Magnuson, E.A

“…Abstract Objectives To obtain Western European perspectives on the economic burden of atherothrombosis in patients with multiple risk factors only (MRF),…”
Get full text

In-Hospital and Long-Term Mortality and Morbidity Burdens in Patients with Acute Coronary Syndromes by Zeymer, U, Domenger, C, Zakouri, B

Get full text

Prognosis of Atrial Fibrillation in Patients with Symptomatic Peripheral Arterial Disease: Data from the REduction of Atherothrombosis for Continued Health (REACH) Registry by Winkel, T.A, Hoeks, S.E, Schouten, O, Zeymer, U, Limbourg, T, Baumgartner, I, Bhatt, D.L, Steg, Ph.G, Goto, S, Röther, J, Cacoub, P.P, Verhagen, H.J.M, Bax, J.J, Poldermans, D

“…Abstract Background Atrial fibrillation (AF) is a significant risk factor for cardiovascular (CV) mortality. This study aims to evaluate the prognostic…”
Get full text

Guideline-adherent therapy in patients with acute coronary syndromes: The EPICOR registry in Germany by Zeymer, U., Heuer, H., Schwimmbeck, P., Genth-Zotz, S., Wolff, K., Nienaber, C.A.

“…Background Representative data on the current management of patients with acute coronary syndromes (ACS) are of high interest. The EPICOR registry aimed to…”
Get full text

Management of different cardiovascular risk factors with a combination tablet (polypill) by Bramlage, P, März, W, Westermann, D, Weisser, B, Wirtz, J H, Zeymer, U, Baumgart, P, van Mark, G, Laufs, U, Krämer, B K, Unger, T

“…The multifactorial origin of cardiovascular diseases has led to polypharmacy in primary and secondary prophylaxis with evidence-based medications, such as…”
Get full text

Ambulatory blood pressure monitoring: Is it mandatory for blood pressure control in treated hypertensive patients? Prospective observational study by LEHMANN, M. V, ZEYMER, U, DECHEND, R, KAISER, E, HAGEDORN, I, DEEG, E, SENGES, J, SCHMIEDER, R. E

“…Twenty-four hour ambulatory blood pressure (ABP) is superior to office blood pressure (BP) in predicting cardiovascular events. However, its use to optimise BP…”
Get full text

Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry by Zeymer, U, Dechend, R, Deeg, E, Kaiser, E, Senges, J, Pittrow, D, Schmieder, R

“…The renin-angiotensin system (RAS) is a key target for blood pressure control and for cardiovascular and renal protection. Aliskiren is the first-in-class…”
Get more information

Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data by The Direct Thrombin Inhibitor Trialists' Collaborative Group

“…To obtain more reliable and precise estimates of the effect of direct thrombin inhibitors in the management of acute coronary syndromes, including patients…”
Get full text